PHREESIA INC (PHR) Stock Fundamental Analysis

NYSE:PHR • US71944F1066

12.71 USD
+0.13 (+1.03%)
At close: Feb 20, 2026
12.9 USD
+0.19 (+1.49%)
After Hours: 2/20/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

PHR gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 35 industry peers in the Health Care Technology industry. The financial health of PHR is average, but there are quite some concerns on its profitability. PHR has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year PHR has reported negative net income.
  • PHR had a positive operating cash flow in the past year.
  • PHR had negative earnings in each of the past 5 years.
  • In multiple years PHR reported negative operating cash flow during the last 5 years.
PHR Yearly Net Income VS EBIT VS OCF VS FCFPHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 -50M -100M -150M

1.2 Ratios

  • PHR's Return On Assets of -1.27% is fine compared to the rest of the industry. PHR outperforms 71.43% of its industry peers.
  • Looking at the Return On Equity, with a value of -1.68%, PHR is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
Industry RankSector Rank
ROA -1.27%
ROE -1.68%
ROIC N/A
ROA(3y)-33.2%
ROA(5y)-26.37%
ROE(3y)-45.91%
ROE(5y)-35.28%
ROIC(3y)N/A
ROIC(5y)N/A
PHR Yearly ROA, ROE, ROICPHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 500 1K

1.3 Margins

  • PHR has a Gross Margin of 68.20%. This is in the better half of the industry: PHR outperforms 68.57% of its industry peers.
  • In the last couple of years the Gross Margin of PHR has remained more or less at the same level.
  • The Profit Margin and Operating Margin are not available for PHR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 68.2%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.16%
GM growth 5Y1.12%
PHR Yearly Profit, Operating, Gross MarginsPHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • PHR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • PHR has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for PHR has been increased compared to 5 years ago.
  • PHR has a worse debt/assets ratio than last year.
PHR Yearly Shares OutstandingPHR Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
PHR Yearly Total Debt VS Total AssetsPHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

2.2 Solvency

  • An Altman-Z score of 3.24 indicates that PHR is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.24, PHR is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
  • PHR has a debt to FCF ratio of 0.27. This is a very positive value and a sign of high solvency as it would only need 0.27 years to pay back of all of its debts.
  • PHR has a Debt to FCF ratio of 0.27. This is in the better half of the industry: PHR outperforms 80.00% of its industry peers.
  • PHR has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
  • PHR's Debt to Equity ratio of 0.01 is in line compared to the rest of the industry. PHR outperforms 57.14% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.27
Altman-Z 3.24
ROIC/WACCN/A
WACC9.62%
PHR Yearly LT Debt VS Equity VS FCFPHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M 300M 400M

2.3 Liquidity

  • PHR has a Current Ratio of 2.44. This indicates that PHR is financially healthy and has no problem in meeting its short term obligations.
  • PHR has a Current ratio (2.44) which is comparable to the rest of the industry.
  • PHR has a Quick Ratio of 2.44. This indicates that PHR is financially healthy and has no problem in meeting its short term obligations.
  • PHR has a Quick ratio (2.44) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.44
Quick Ratio 2.44
PHR Yearly Current Assets VS Current LiabilitesPHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • PHR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 93.75%, which is quite impressive.
  • Looking at the last year, PHR shows a quite strong growth in Revenue. The Revenue has grown by 14.33% in the last year.
  • The Revenue has been growing by 27.46% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)93.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%140%
Revenue 1Y (TTM)14.33%
Revenue growth 3Y25.34%
Revenue growth 5Y27.46%
Sales Q2Q%12.67%

3.2 Future

  • PHR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 43.29% yearly.
  • PHR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.34% yearly.
EPS Next Y117.04%
EPS Next 2Y62.49%
EPS Next 3Y43.29%
EPS Next 5YN/A
Revenue Next Year14.63%
Revenue Next 2Y14.85%
Revenue Next 3Y12.9%
Revenue Next 5Y11.34%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
PHR Yearly Revenue VS EstimatesPHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M
PHR Yearly EPS VS EstimatesPHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 -1 -2

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • PHR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • PHR is valuated rather expensively with a Price/Forward Earnings ratio of 19.46.
  • 74.29% of the companies in the same industry are more expensive than PHR, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 28.02. PHR is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 19.46
PHR Price Earnings VS Forward Price EarningsPHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100 -150

4.2 Price Multiples

  • PHR's Enterprise Value to EBITDA is on the same level as the industry average.
  • PHR's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. PHR is cheaper than 68.57% of the companies in the same industry.
Industry RankSector Rank
P/FCF 21.84
EV/EBITDA 33.61
PHR Per share dataPHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as PHR's earnings are expected to grow with 43.29% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y62.49%
EPS Next 3Y43.29%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • PHR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PHREESIA INC

NYSE:PHR (2/20/2026, 8:04:00 PM)

After market: 12.9 +0.19 (+1.49%)

12.71

+0.13 (+1.03%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)12-08
Earnings (Next)03-10
Inst Owners102.75%
Inst Owner Change-3.61%
Ins Owners5.31%
Ins Owner Change5.27%
Market Cap766.29M
Revenue(TTM)463.20M
Net Income(TTM)-5.38M
Analysts84.17
Price Target29.2 (129.74%)
Short Float %5.65%
Short Ratio1.88
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8258.63%
Min EPS beat(2)115.6%
Max EPS beat(2)16401.7%
EPS beat(4)4
Avg EPS beat(4)4149.43%
Min EPS beat(4)38.81%
Max EPS beat(4)16401.7%
EPS beat(8)8
Avg EPS beat(8)2083.66%
EPS beat(12)12
Avg EPS beat(12)1396.19%
EPS beat(16)16
Avg EPS beat(16)1052.44%
Revenue beat(2)0
Avg Revenue beat(2)-0.56%
Min Revenue beat(2)-0.76%
Max Revenue beat(2)-0.37%
Revenue beat(4)0
Avg Revenue beat(4)-0.4%
Min Revenue beat(4)-0.76%
Max Revenue beat(4)-0.18%
Revenue beat(8)1
Avg Revenue beat(8)-0.37%
Revenue beat(12)4
Avg Revenue beat(12)0.17%
Revenue beat(16)8
Avg Revenue beat(16)0.55%
PT rev (1m)-1.8%
PT rev (3m)-15.29%
EPS NQ rev (1m)8.68%
EPS NQ rev (3m)211.43%
EPS NY rev (1m)-10.88%
EPS NY rev (3m)609.87%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)2.28%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.69%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 19.46
P/S 1.65
P/FCF 21.84
P/OCF 12.48
P/B 2.39
P/tB 4.65
EV/EBITDA 33.61
EPS(TTM)-0.07
EYN/A
EPS(NY)0.65
Fwd EY5.14%
FCF(TTM)0.58
FCFY4.58%
OCF(TTM)1.02
OCFY8.01%
SpS7.68
BVpS5.31
TBVpS2.73
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.27%
ROE -1.68%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 68.2%
FCFM 7.58%
ROA(3y)-33.2%
ROA(5y)-26.37%
ROE(3y)-45.91%
ROE(5y)-35.28%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.16%
GM growth 5Y1.12%
F-Score7
Asset Turnover1.09
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.27
Debt/EBITDA 0.17
Cap/Depr 92.06%
Cap/Sales 5.68%
Interest Coverage N/A
Cash Conversion 308.26%
Profit Quality N/A
Current Ratio 2.44
Quick Ratio 2.44
Altman-Z 3.24
F-Score7
WACC9.62%
ROIC/WACCN/A
Cap/Depr(3y)91.68%
Cap/Depr(5y)107.3%
Cap/Sales(3y)7.37%
Cap/Sales(5y)9.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)93.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%140%
EPS Next Y117.04%
EPS Next 2Y62.49%
EPS Next 3Y43.29%
EPS Next 5YN/A
Revenue 1Y (TTM)14.33%
Revenue growth 3Y25.34%
Revenue growth 5Y27.46%
Sales Q2Q%12.67%
Revenue Next Year14.63%
Revenue Next 2Y14.85%
Revenue Next 3Y12.9%
Revenue Next 5Y11.34%
EBIT growth 1Y89.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year266.33%
EBIT Next 3Y65.66%
EBIT Next 5Y38.03%
FCF growth 1Y150.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y235.86%
OCF growth 3YN/A
OCF growth 5Y108.09%

PHREESIA INC / PHR FAQ

Can you provide the ChartMill fundamental rating for PHREESIA INC?

ChartMill assigns a fundamental rating of 4 / 10 to PHR.


What is the valuation status of PHREESIA INC (PHR) stock?

ChartMill assigns a valuation rating of 4 / 10 to PHREESIA INC (PHR). This can be considered as Fairly Valued.


Can you provide the profitability details for PHREESIA INC?

PHREESIA INC (PHR) has a profitability rating of 2 / 10.


What is the expected EPS growth for PHREESIA INC (PHR) stock?

The Earnings per Share (EPS) of PHREESIA INC (PHR) is expected to grow by 117.04% in the next year.


Can you provide the dividend sustainability for PHR stock?

The dividend rating of PHREESIA INC (PHR) is 0 / 10 and the dividend payout ratio is 0%.